PDT

PDT's PHOTONIC TUMOR THERAPY is used since 2004 in humans in leading Austrian Tumor Centers in well-selected indications on named-patient base. Since then excellent clinical data of the side effect free therapy have led physicians to expand the use into multiple other indications. After being granted CE Mark for its third generation ultimate high power catheter-based, therapy laser PDT is engaged in the commercialization of its reimbursed technology with the support of its CE marked field-specialist service... To ensure the most efficient use of its technology throughout all territories and medical disciplines and to offer its partners a highly efficient hands-on training and support facility, PDT is establishing a KNOW HOW TRANSFER CENTER near Vienna, Austria... Only for the currently targeted indications, i.e. cancer of the bile duct, bladder, gastric cardia, cervix, colon, esophagus (Barrett's), lung, pancreas, and rectum, approximately 1,6M new cases in the EC and approximately..

Primary location: Vienna Austria